Joinn Laboratories(China)Co.,Ltd. (6127.HK) HKSE

Currency In HKD

AD

Joinn Laboratories(China)Co.,Ltd.

Address

A5 Rongjing East Street

Beijing, 100176

China

Phone

86 10 6786 9966

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Employees

2510

First IPO Date

February 26, 2021

Key Executives

NameTitlePayYear Born
Dapeng GaoGM, Secretary to the Board, Joint Company Secretary & Executive Director01982
Jingliang GuVice GM, Head of Sales Department and Executive Director01980
Aishui YuChief Financial Officer01976
Xi LuoExecutive Director01978
Yuxia FengFounder & Chairman01964
Yunxia Sun DCBTVice GM & Executive Director01968
Dalin YaoChief Scientific Officer01949
AD

Description

Joinn Laboratories (China) Co., Ltd. is a global provider of essential preclinical and non-clinical research services, operating across the United States, mainland China, and various international markets. The company organizes its operations into three primary divisions: Non-Clinical Studies, Clinical Trial and Related Services, and Research Model Sales. The Non-Clinical Studies segment specializes in comprehensive drug safety assessments, pharmacokinetic and drug metabolism research, and pharmacology and efficacy investigations. Within its Clinical Trial and Related Services segment, the firm delivers clinical contract research organization (CRO) support, co-manages specialized Phase I clinical research facilities, and provides bioanalytical testing. The Research Model Sales division is responsible for the development, breeding, and distribution of diverse animal models for research purposes, encompassing non-human primates and rodents. Furthermore, Joinn Laboratories also extends its offerings to include investment management and cell-based assay (CBA) services. Established in 1995, the company is headquartered in Beijing, China.

AD